摘要 |
Compounds of Formula I and pharmaceutically acceptable salts thereof, are useful for inhibiting receptor tyrosine kinases and for treating disorders mediated thereby. Methods of using compounds of Formula I and pharmaceutically acceptable salts thereof, for in vitro, in situ, and in vivo diagnosis, prevention or treatment of such disorders in mammalian cells, or associated pathological conditions are disclosed. |
申请人 |
ARRAY BIOPHARMA INC.;BLAKE, JAMES, F.;BOYD, STEVEN;DE MEESE, JASON;GAUDINO, JOHN, J.;MARLOW, ALLISON, L.;SEO, JEONGBEOB;THOMAS, ALLEN, A.;TIAN, HONGQI |
发明人 |
BLAKE, JAMES, F.;BOYD, STEVEN;DE MEESE, JASON;GAUDINO, JOHN, J.;MARLOW, ALLISON, L.;SEO, JEONGBEOB;THOMAS, ALLEN, A.;TIAN, HONGQI |